Basso Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,100
Closed -$680K 174
2017
Q3
$680K Buy
+11,100
New +$680K 0.08% 122